Prospective Feasibility Trial of AccuCath 2.25" Blood Control (BC) Placed in Difficult Access Patients in the Emergency Department

Completed · Not applicable

Conditions studied: Vascular Access Complication

In brief

Study objective is to evaluate user preference, time for procedure, insertion success rates, complications, completion of therapy and dwell time of the AccuCath 2.25" BC device placed in difficult IV access patients in the emergency department.

Key facts

Study ID

NCT02449798

Run by

C. R. Bard

People needed

120

Starts

2015-03-01

Expected to finish

2015-07-01

Last updated by the study team

2017-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, age > 18 years old;
• Capable and willing to give informed consent;
• English speaking;
• Acceptable candidate for an elective, non-emergent peripheral IV as determined by ordering physician;
• Admitted to inpatient area for minimum of 24 hours, preferably for average hospital length of stay;
• Difficult venous access patient as defined by either 2 failed initial attempts without ultrasound guidance or a history of difficult access plus the inability to directly visualize or palpate a target vein.

You may not qualify if…

• Male or female, < 18 years old;
• Requirement for emergent IV placement (patient's condition would be compromised if there is a delay in IV placement);
• Previous venous grafts or surgery at the target vessel access site;
• Subjects with lymphedema or status-post mastectomy on affected side;
• Currently involved in other investigational clinical trials (unless permission is granted by other study PI).

Where it is running

• North Shore - Long Island Jewish Health System — Manhasset, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.